Anavex Life Sciences Corp. (AVXL)
NASDAQ: AVXL · Real-Time Price · USD
9.02
+0.55 (6.43%)
At close: Nov 21, 2024, 4:00 PM
9.10
+0.08 (0.89%)
After-hours: Nov 21, 2024, 4:14 PM EST
Anavex Life Sciences Ratios and Metrics
Market cap in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 21, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
| Market Capitalization | 765 | 537 | 804 | 1,359 | 274 | 166 | |
| Market Cap Growth | -45.65% | -33.27% | -40.82% | 396.34% | 64.61% | 34.14% | |
| Enterprise Value | 580 | 382 | 651 | 1,202 | 246 | 145 | |
| Last Close Price | 8.47 | 6.55 | 10.32 | 17.95 | 4.55 | 3.16 | |
| PB Ratio | 5.54 | 3.78 | 5.65 | 9.01 | 10.06 | 8.20 | |
| P/TBV Ratio | 2.75 | 3.78 | 5.65 | 9.01 | 10.06 | 8.20 | |
| Quick Ratio | 11.95 | 12.27 | 14.92 | 14.93 | 4.67 | 4.93 | |
| Current Ratio | 12.04 | 12.32 | 14.95 | 14.97 | 4.73 | 5.03 | |
| Return on Equity (ROE) | -30.03% | -33.41% | -32.71% | -42.58% | -110.59% | -123.42% | |
| Return on Assets (ROA) | -20.43% | -21.59% | -18.95% | -23.87% | -55.77% | -64.62% | |
| Return on Capital (ROIC) | -22.12% | -23.32% | -20.31% | -26.29% | -70.26% | -78.15% | |
| Earnings Yield | -5.37% | -8.85% | -5.96% | -2.79% | -9.60% | -15.80% | |
| FCF Yield | -3.88% | -5.18% | -3.01% | -2.24% | -7.77% | -11.14% | |
| Buyback Yield / Dilution | -5.06% | -3.74% | -10.18% | -19.95% | -18.99% | -9.52% | |
| Total Shareholder Return | -5.06% | -3.74% | -10.18% | -19.95% | -18.99% | -9.52% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.